Microsoft Word search phase 3 Title Page Amendment

3.
 
STUDY ORGANIZATION .................................................................................................. 1
 
3.1.
 
PARTICIPANT
 
ORGANIZATION ............................................................................... 1
 
3.1.1.
  Study Centers .............................................................................................................. 1 
3.1.2.
  Coordinating Center ................................................................................................... 1 
3.1.3.
  Central Laboratory ..................................................................................................... 2 
3.1.4.
  Federal Sponsors ........................................................................................................ 2 
3.1.5.
  External Scientific Evaluation Committee (ESEC) ..................................................... 2 
3.1.6.
  Data Ownership .......................................................................................................... 3 
3.2.
 
COMMITTEE
 
STRUCTURE .........................................................................................  3
 
3.2.1.
  Study-wide Committees ............................................................................................... 3 
3.2.1.1.
  Study Group ........................................................................................................ 3 
3.2.1.2.
  Steering Committee ............................................................................................ 3 
3.2.1.3.
  Executive Committee .......................................................................................... 4 
3.2.1.4.
  Protocol Oversight Committee ........................................................................... 4 
3.2.1.5.
  Publications and Presentations Committee ......................................................... 4 
3.2.1.6.
  Ancillary Studies Committee .............................................................................. 5 
3.2.1.7.
  Registry Oversight Committee ........................................................................... 5 
3.2.1.8.
  Outcomes Committee .......................................................................................... 5 
3.2.1.9.
  Recruitment and Retention Committee ............................................................... 5 
3.2.1.10.
  Project Managers Committee .............................................................................. 5 
3.2.2.
  Face-to-Face Meetings ............................................................................................... 6 
3.3.
 
SEARCH
 
COLLABORATORS ..................................................................................... 6
 
3.3.1.
  Clinical Centers .......................................................................................................... 6 
3.3.2.
  Coordinating Center ................................................................................................... 7 
3.3.3.
  Federal Sponsors ........................................................................................................ 7 
3.3.4.
  Central Laboratory ..................................................................................................... 7 
 

---

Section 3 - Study Organization (Phase 3 - 12/2010) 
Section 3 - Page 1